Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brouwer

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
British Journal of Haematology|October 11, 2011
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programmeLieke H van der Helm, Canan Alhan, Pierre W Wijermans, et al.
Microbiology Resource Announcements|October 31, 2023
Complete genome sequences of microbacterium phages Tedro and BAjuniperGrace M Anderson, Olivia E Anderson, Clayton A Bosma, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
Blood|January 24, 2016
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myelomaSonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, et al.
Thrombosis Research|June 28, 2026
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra StudyE S L Martens, B Akerboom, C Baumgartner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)Pieternella Johanna Lugtenburg, Peter de Nully Brown, Bronno van der Holt, et al.
Annals of the Rheumatic Diseases|February 18, 2014
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptidesL Bossini-Castillo, C de Kovel, H Kallberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult CareAnnouschka M Weijsenfeld, Colette Smit, Sophie Cohen, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
British Journal of Haematology|October 11, 2011
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programmeLieke H van der Helm, Canan Alhan, Pierre W Wijermans, et al.
Microbiology Resource Announcements|October 31, 2023
Complete genome sequences of microbacterium phages Tedro and BAjuniperGrace M Anderson, Olivia E Anderson, Clayton A Bosma, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
Blood|January 24, 2016
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myelomaSonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, et al.
Thrombosis Research|June 28, 2026
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra StudyE S L Martens, B Akerboom, C Baumgartner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)Pieternella Johanna Lugtenburg, Peter de Nully Brown, Bronno van der Holt, et al.
Annals of the Rheumatic Diseases|February 18, 2014
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptidesL Bossini-Castillo, C de Kovel, H Kallberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult CareAnnouschka M Weijsenfeld, Colette Smit, Sophie Cohen, et al.
Pageof 20